ClinicalTrialsFinder

Cutaneous T-Cell Lymphoma Refractory Clinical Trials in Los Angeles, California

1 recruitingLos Angeles, California

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

T-cell Prolymphocytic LeukemiaCutaneous T-Cell Lymphoma Refractory
Jonsson Comprehensive Cancer Center12 enrolled1 locationNCT06810778